IT Mac 10mg Oral Solution contains itraconazole, a triazole antifungal agent, at a concentration of 10mg per milliliter. It is indicated for the treatment of various fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and onychomycosis, as well as other systemic and superficial mycoses caused by susceptible fungi. Itraconazole exerts its antifungal effect by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for ergosterol synthesis, a critical component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. IT Mac 10mg Oral Solution is formulated for oral administration, allowing for flexible dosing in patients who may have difficulty swallowing capsules. The solution exhibits good bioavailability when taken with food, enhancing absorption. Dosage and duration of therapy should be individualized based on the type and severity of infection, patient response, and clinical judgment. Caution is advised in patients with hepatic impairment or congestive heart failure, and potential drug interactions must be carefully monitored due to itraconazole’s effect on cytochrome P450 enzymes. Adverse effects may include gastrointestinal disturbances, headache, and elevated liver enzymes. Regular monitoring during therapy is recommended to ensure safety and efficacy.